Definitive Healthcare Corp.

Annual Trend FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Revenue $118.3m $166.2m $222.7m $251.4m $252.2m $241.5m
Cost of revenue exclusive of amortization $11.1m $19.4m $25.9m $34.7m $40.7m $38.0m
Gross profit $87.8m $125.5m $180.0m $203.9m $197.5m $183.3m
Total operating expenses $102.3m $150.4m $221.3m $533.7m $908.3m $407.5m
Amortization $19.4m $21.3m $16.8m $12.7m $14.0m $20.3m
Sales and marketing $34.3m $56.4m $89.6m $94.5m $83.8m $81.6m
Product development $11.1m $18.6m $34.9m $42.4m $36.5m $34.8m
General and administrative $12.9m $30.5m $48.8m $58.9m $49.3m $51.6m
Depreciation and amortization $40.2m $38.7m $40.1m $39.0m $37.6m $35.8m
Goodwill impairment $0 $0 $287.4m $688.9m $196.1m
Loss from operations ($14.4m) ($25.0m) ($41.3m) ($329.8m) ($710.8m) ($224.3m)
Interest income $29k $2.8m $13.6m $14.6m $7.0m
Gain on remeasurement of TRA liability $9.7m $23.5m $76.9m $21.7m
Loss on partial extinguishment of debt $0 ($9.9m) $0 $0 $0 ($507k)
Loss before income taxes ($51.2m) ($60.6m) ($39.4m) ($308.2m) ($633.7m) ($209.3m)
Benefit from income taxes ($62k) ($675k) $17.2m $18.6m $42.3m $10.0m
Net loss ($51.2m) ($61.3m) ($22.3m) ($289.6m) ($591.4m) ($199.3m)
Less: Net loss attributable to noncontrolling interests $0 ($10.2m) ($16.2m) ($87.2m) ($178.3m) ($60.4m)
Net loss attributable to Definitive Healthcare Corp. ($51.2m) ($17.7m) ($6.0m) ($202.4m) ($413.1m) ($138.9m)
Total other income, net ($36.7m) ($35.6m) $1.8m $21.6m $77.1m $15.0m
Basic ($0.19) ($0.06) ($1.79) ($3.54) ($1.30)
Diluted ($0.19) ($0.06) ($1.79) ($3.54) ($1.30)
Transaction, integration, and restructuring expenses $3.8m $6.3m $7.9m $11.5m $12.2m $7.6m
Interest expense ($36.5m) ($25.9m) ($8.4m) ($15.2m) ($14.8m) ($11.3m)
Other (expense) income, net ($222k) $143k $10.2m $23.2m $411k ($1.8m)